SHL Telemedicine (SHLT) Stock Price, News & Analysis

$5.38
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$5.38
$5.38
50-Day Range
$5.05
$6.70
52-Week Range
$4.86
$12.75
Volume
64 shs
Average Volume
5,906 shs
Market Capitalization
$78.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

SHL Telemedicine MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
104.5% Upside
$11.00 Price Target
Short Interest
Healthy
0.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.36 out of 5 stars

Medical Sector

699th out of 909 stocks

Offices & Clinics Of Medical Doctors Industry

5th out of 7 stocks

SHLT stock logo

About SHL Telemedicine Stock (NASDAQ:SHLT)

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.

SHLT Stock Price History

SHLT Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
SHL Telemedicine Ltd. (SHLT)
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
SHL Telemedicine Ltd ADR - New SHLT
See More Headlines
Receive SHLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SHL Telemedicine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/24/2024
Next Earnings (Estimated)
7/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:SHLT
Fax
N/A
Employees
402
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.00
High Stock Price Target
$11.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+104.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$57.08 million
Cash Flow
$0.04 per share
Book Value
$5.21 per share

Miscellaneous

Free Float
N/A
Market Cap
$78.98 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Erez Nachtomy (Age 62)
    Chief Executive Officer
    Comp: $426.97k
  • Mr. Amir Hai (Age 58)
    Chief Financial Officer
  • Mr. Linus Drop (Age 51)
    Co-Managing Director of SHL Telemedizin Germany
  • Mr. Bernd Altpeter
    Co-Managing Director of SHL Telemedizin Germany

SHLT Stock Analysis - Frequently Asked Questions

Should I buy or sell SHL Telemedicine stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SHL Telemedicine in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SHLT shares.
View SHLT analyst ratings
or view top-rated stocks.

What is SHL Telemedicine's stock price target for 2024?

1 analysts have issued 1 year price objectives for SHL Telemedicine's shares. Their SHLT share price targets range from $11.00 to $11.00. On average, they expect the company's share price to reach $11.00 in the next year. This suggests a possible upside of 104.5% from the stock's current price.
View analysts price targets for SHLT
or view top-rated stocks among Wall Street analysts.

How have SHLT shares performed in 2024?

SHL Telemedicine's stock was trading at $7.98 at the beginning of the year. Since then, SHLT shares have decreased by 32.6% and is now trading at $5.38.
View the best growth stocks for 2024 here
.

Are investors shorting SHL Telemedicine?

SHL Telemedicine saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,600 shares, an increase of 62.5% from the March 15th total of 1,600 shares. Based on an average daily volume of 3,900 shares, the short-interest ratio is presently 0.7 days.
View SHL Telemedicine's Short Interest
.

When is SHL Telemedicine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 17th 2024.
View our SHLT earnings forecast
.

How do I buy shares of SHL Telemedicine?

Shares of SHLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SHLT) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners